Pharmacovigilance

The Assign Group provides complete pharmacovigilance services. At the center of our pharmacovigilance process is patient safety and regulatory compliance. Patient safety narratives are written with input provided by the Assign cross-functional teams, who are reviewing all available data and information (e.g., pharmacovigilance database, clinical trial database, CIOMS forms, hospital records, case report forms).

Pharmacovigilance services:

  • Review of Clinical Study Protocol
  • Set-up of DSMB, DSMB reports
  • Set-up and maintenance of safety database
  • SAE handling manuals , Medical review of SAEs and follow-up , Medical assessment of causality and expectedness
  • Expedited reports (SUSARs) to CAs and ECs/Investigators
  • SAE tracking and update of SAE documentation , Coding (MedDRA, WHO-DD, ATC)
  • Generation of CIOMS-I forms and line listings
  • SAE reconciliation
  • Periodic Safety Reports (PSURs)

News

16/01/2012

3rd Annual Advancing Biol...

January 30-31, Munich, Germany. The Assign Group is happy to...

12/01/2012

Faster and cheaper: Centr...

Bioforum reports in January 2012:“In my opinion as well as in the...

10/01/2012

New Benelux Assign-Office...

Source: Pharmasite: 19-12-2011, Bron: ...

05/12/2011

Annual Congress of Clinic...

December 8-10, Debrecen, Hungary, Dr. Kata Mazalin, CMO of the...

04/11/2011

10th Annual Partnerships ...

November 15-18, 2011, Lyon France - The PCT meeting is a great event...

12/10/2011

3rd Annual Partnership in...

October 12/14, 2011 Shanghai China - Partnerships in Clinical Trial...

30/08/2011

3. European Consensus Con...

November 10-12, 2011, Berlin, Germany - Assign Group as...

15/07/2011

"Hürdenlauf Arzneimitteli...

07.10.2011, Vienna, AustriaArcotel Kaiserwasser, GPMed in...

08/04/2011

PCMG Annual Conference 20...

Dubrovnik, Croatia, June 8 - 10, 2011

29/03/2011

Outsourcing Conference

Dubrovnik, June 2011 – joined meeting Assign/ABF

04/03/2011

DIA 2011 47th Annual Meet...

Chicago, June 2011 – joined booth Assign/ABF